ConductScience.org, home

Trial · NCT03070730

Registered outcomes42

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Maximal Postural Tachycardia During TiltUp to 3 days after randomizationMaximal postural tachycardia is the maximum heart rate during a 20-min tilt table test.
PrimaryChange Maximal Postural Tachycardia During Tilt2 weeks after first interventionMaximal postural tachycardia is the maximum heart rate during a 20-min tilt table test.
PrimaryChange Maximal Postural Tachycardia During Tilt2 weeks after second interventionMaximal postural tachycardia is the maximum heart rate during a 20-min tilt table test.
PrimaryChange in Fatigue Score on the Chalder Fatigue Questionnaire From Baselineup to 3 days after randomizationA 14 item self-report questionnaire. Subjects respond on a continuum of 1 to 4 questions evaluating fatigue intensity while distinguishing physical from mental fatigue.
PrimaryChange in Fatigue Score on the Chalder Fatigue Questionnaire From Baseline2 weeks after first interventionA 14 item self-report questionnaire. Subjects respond on a continuum of 1 to 4 questions evaluating fatigue intensity while distinguishing physical from mental fatigue.
PrimaryChange in Fatigue Score on the Chalder Fatigue Questionnaire From Baseline2 weeks after second interventionA 14 item self-report questionnaire. Subjects respond on a continuum of 1 to 4 questions evaluating fatigue intensity while distinguishing physical from mental fatigue.
SecondaryChange in Blood Pressure From Baseline1 week after first intervention
SecondaryChange in Blood Pressure From Baseline1 week after second intervention
SecondaryChange in Blood Pressure From Baseline1 week after third intervention
SecondaryChange in Heart Rate From Baseline1 week after first intervention
SecondaryChange in Heart Rate From Baseline1 week after second intervention
SecondaryChange in Heart Rate From Baseline1 week after third intervention
SecondaryChange in Vascular Resistance From Baseline1 week after first intervention
SecondaryChange in Vascular Resistance From Baseline1 week after second intervention
SecondaryChange in Vascular Resistance From Baseline1 week after third intervention
SecondaryChange in Muscle Sympathetic Nerve Activity From Baseline1 week after first intervention
SecondaryChange in Muscle Sympathetic Nerve Activity From Baseline1 week after second intervention
SecondaryChange in Muscle Sympathetic Nerve Activity From Baseline1 week after third intervention
SecondaryChange in Physical Functioning-SF-36 Q From Baseline1 week after first interventionMeasures of follow up testing will be the scores on the physical functioning subscale of the SF-36 questionnaire.
SecondaryChange in Physical Functioning-SF-36 Q From Baseline1 week after second interventionMeasures of follow up testing will be the scores on the physical functioning subscale of the SF-36 questionnaire.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03070730/registered